Agile Therapeutics, Inc. (AGRX)
Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)
1.510
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2024
Agile Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
| 10 | 10 | 2 | 5 | 5 | 3 | 10 | 9 | 12 | 14 | 28 | 59 | 89 | 117 | 182 | 251 | 265 | 242 | 158 | 148 | 70 | |
Market Cap Growth (YoY) | - | 218.43% | -77.64% | -46.88% | -60.09% | -78.86% | -63.04% | -84.44% | -87.04% | -87.73% | -84.53% | -76.39% | -66.32% | -51.58% | 15.54% | 69.26% | 277.67% | 279.64% | 141.75% | 648.87% | 457.74% |
Enterprise Value | 8 | 7 | 2 | 5 | 5 | 1 | 7 | 5 | 12 | 25 | 27 | 61 | 74 | 93 | 144 | 195 | 194 | 164 | 123 | 130 | 60 |
Last Close Price | 1.51 | 1.41 | 0.34 | 1.95 | 2.40 | 2.95 | 11.20 | 11.35 | 14.85 | 58.25 | 419.00 | 976.20 | 1922.20 | 2660.00 | 4160.00 | 5740.00 | 6080.00 | 5560.00 | 3720.00 | 5000.00 | 2370.00 |
Price Ratios
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
PE Ratio | - | -0.39 | -0.13 | -0.29 | -0.28 | -0.16 | -0.35 | -0.19 | -0.09 | -0.07 | -0.35 | -0.67 | -1.24 | -1.72 | -2.98 | -4.69 | -5.92 | -6.68 | -5.05 | -6.64 | -3.06 |
PS Ratio | 0.31 | 0.45 | 0.11 | 0.25 | 0.23 | 0.19 | 0.81 | 0.85 | 1.38 | 2.15 | 4.91 | 14.45 | 26.79 | 57.26 | 210.71 | 335.03 | - | - | - | - | - |
PB Ratio | - | -0.44 | -0.23 | -0.30 | -0.37 | -0.25 | -1.10 | -1.66 | 1.85 | 4.21 | 10.28 | 15.13 | 8.37 | 4.77 | 5.20 | 5.09 | 4.01 | 3.00 | 1.74 | 3.24 | 2.20 |
P/FCF Ratio | - | -5.68 | -0.22 | -0.51 | -0.41 | -0.11 | -0.46 | -0.26 | -0.23 | -0.27 | -0.43 | -0.91 | -1.35 | -1.86 | -3.35 | -5.26 | -7.90 | -10.40 | -8.36 | -9.39 | -4.51 |
P/OCF Ratio | - | -5.68 | -0.22 | -0.51 | -0.41 | -0.11 | -0.46 | -0.26 | -0.23 | -0.27 | -0.43 | -0.91 | -1.36 | -1.87 | -3.37 | -5.30 | -7.98 | -10.54 | -8.48 | -9.45 | -4.52 |
EV Ratios
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
EV/Sales Ratio | 0.36 | 0.35 | 0.09 | 0.23 | 0.23 | 0.05 | 0.57 | 0.48 | 1.44 | 3.70 | 4.67 | 14.87 | 22.29 | 45.38 | 166.84 | 260.54 | - | - | - | - | - |
EV/EBITDA Ratio | - | -0.57 | -0.13 | -0.23 | -0.20 | -0.03 | -0.23 | -0.13 | -0.22 | -0.39 | -0.39 | -0.89 | -1.17 | -1.48 | -2.54 | -4.00 | -5.07 | -5.84 | -5.71 | -6.96 | -3.73 |
EV/EBIT Ratio | - | -0.55 | -0.12 | -0.23 | -0.20 | -0.03 | -0.23 | -0.13 | -0.21 | -0.38 | -0.38 | -0.86 | -1.14 | -1.45 | -2.50 | -3.98 | -5.05 | -5.81 | -5.67 | -6.90 | -3.71 |
EV/FCF Ratio | - | -4.37 | -0.19 | -0.47 | -0.40 | -0.03 | -0.32 | -0.14 | -0.24 | -0.47 | -0.41 | -0.93 | -1.12 | -1.48 | -2.66 | -4.09 | -5.77 | -7.04 | -6.54 | -8.24 | -3.85 |
Financial Efficiency
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Debt / Equity Ratio | -0.01 | -0.01 | -0.04 | -0.13 | -0.20 | -0.22 | -0.23 | -0.40 | 0.34 | 3.95 | 4.81 | 4.54 | 1.54 | 0.65 | 0.45 | 0.33 | 0.24 | 0.20 | 0.17 | 0.00 | 0.01 |
Debt / FCF Ratio | -0.17 | -0.17 | -0.04 | -0.23 | -0.22 | -0.09 | -0.10 | -0.06 | -0.04 | -0.25 | -0.20 | -0.27 | -0.25 | -0.26 | -0.29 | -0.35 | -0.48 | -0.68 | -0.83 | -0.01 | -0.01 |
Asset Turnover | 1.57 | 1.57 | 1.63 | 1.60 | 1.36 | 0.72 | 0.60 | 0.41 | 0.30 | 0.16 | 0.13 | 0.07 | 0.05 | 0.03 | 0.01 | 0.01 | - | - | - | - | - |
Inventory Turnover | 1.88 | 1.88 | 2.90 | 4.41 | 4.01 | 3.03 | 2.98 | 5.95 | 4.14 | 4.20 | 5.18 | - | - | - | - | - | - | - | - | - | - |
Quick Ratio | 0.28 | 0.28 | 0.35 | 0.29 | 0.36 | 0.47 | 0.41 | 0.64 | 0.85 | 0.53 | 0.39 | 0.71 | 1.68 | 2.77 | 4.60 | 7.53 | 9.98 | 13.44 | 33.45 | 9.09 | 9.69 |
Current Ratio | 0.55 | 0.55 | 0.56 | 0.46 | 0.57 | 0.76 | 0.59 | 0.85 | 1.33 | 0.64 | 0.56 | 0.82 | 2.27 | 3.18 | 4.97 | 7.72 | 10.18 | 13.67 | 33.69 | 9.31 | 10.39 |
Return on Equity (ROE) | - | - | - | - | - | - | - | - | -484.19% | -370.02% | -340.37% | -266.95% | -180.07% | -128.85% | -97.24% | -109.08% | -82.12% | -56.16% | -37.86% | -56.45% | -59.53% |
Return on Assets (ROA) | -61.55% | -61.55% | -75.71% | -101.46% | -96.71% | -72.40% | -94.69% | -96.67% | -129.01% | -95.62% | -99.06% | -78.97% | -64.82% | -51.72% | -42.81% | -50.01% | -38.96% | -27.60% | -20.15% | -32.77% | -30.90% |
Return on Invested Capital (ROIC) | - | - | - | - | - | -438.79% | -467.09% | -281.89% | -200.09% | -141.20% | -131.79% | -101.37% | -74.72% | -58.48% | -45.91% | -54.86% | -41.99% | -29.45% | -20.75% | -35.67% | -33.04% |
Yields
Fiscal Quarter | Current | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 26, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Earnings Yield | -152.10% | -163.57% | -334.22% | -295.34% | -301.19% | -625.92% | -195.85% | -275.63% | -353.97% | -360.11% | -228.08% | -119.94% | -77.37% | -57.85% | -33.52% | -20.66% | -15.17% | -12.03% | -13.83% | -12.55% | -23.33% |
FCF Yield | -16.36% | -17.60% | -448.63% | -195.54% | -244.57% | -932.04% | -218.69% | -391.34% | -441.86% | -369.01% | -232.64% | -110.49% | -74.06% | -53.62% | -29.82% | -18.99% | -12.66% | -9.62% | -11.96% | -10.65% | -22.18% |
Buyback Yield / Dilution | -308.85% | -308.85% | -378.81% | -398.99% | -576.06% | -1548.13% | -1112.69% | -790.51% | -436.32% | -47.29% | -21.61% | -14.63% | -13.85% | -25.21% | -47.51% | -71.31% | -85.60% | -87.14% | -68.92% | -44.05% | -23.44% |
Total Shareholder Return | -308.85% | -308.85% | -378.81% | -398.99% | -576.06% | -1548.13% | -1112.69% | -790.51% | -436.32% | -47.29% | -21.61% | -14.63% | -13.85% | -25.21% | -47.51% | -71.31% | -85.60% | -87.14% | -68.92% | -44.05% | -23.44% |